Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Verge Capital Management Pte Ltd is a Singapore-based venture capital firm founded to invest in healthtech innovations. The firm focuses on enhancing the accessibility, quality, and efficiency of healthcare through transformative technologies. It manages a portfolio of six companies and operates primarily in the United States, Australia, Spain, the United Kingdom, and Singapore.
Verge Capital Management invests in healthtech companies at pre-seed and seed stages, targeting early revenue and pre-regulatory phases. The firm seeks out transformative technologies that can significantly impact the healthcare system. Their geographical focus includes Asia, Australia, Spain, the United Kingdom, and the United States.
Notable portfolio companies include Tachin.ai, an AI-enabled operating system for healthcare; Understanding Zoe, which connects caretakers for neurodivergent children; Zoundream, analyzing infant voices with AI; BotMD, a chat-first automation platform for patient engagement; Lifeyear, managing cardiovascular disease patients; and Macuject, a clinical decision support SaaS for age-related macular degeneration.
Submit your pitch through their form at vergecm.com.
Yes, Verge Capital Management often leads investment rounds in their target sectors, particularly in healthtech.
The firm is open to follow-on investments, especially in companies that demonstrate significant growth and alignment with their investment thesis.
Specific details about the fund size are not disclosed, but the firm actively manages a portfolio of six companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.